当前位置:主页 > 临床病例 > 文章内容

National Cancer Center, Chinese Academy of Medical Sciences

作者:中华医学网发布时间:2026-04-22 11:04浏览:

 Full Name: National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (NCC/CH-CAMS)Former Name: Ritan HospitalAffiliation: National Health Commission; Chinese Academy of Medical Sciences & Peking Union Medical CollegeLevel: National Grade A Tertiary Oncology HospitalMotto: Unity, Dedication, Dedication, Innovation (团结、奉献、敬业、创新)Reputation: China’s first and most prestigious national cancer hospital; flagship institution for cancer care, research, education and prevention.
Basic Profile & History
Founded in 1958 as Ritan Hospital, it is the first oncology specialist hospital in the People’s Republic of China.
1963: Established the Institute of Oncology.
1983: Relocated to Longtan Lake (Chaoyang District) and renamed Cancer Hospital & Institute, CAMS.
1996: Accredited as Grade A Tertiary Hospital.
2009: Became the host institution of the National Cancer Center (NCC).
2021: Designated as one of China’s first “Guidance-Type” National Medical Centers.
Location & Campuses:
Main Campus: 17 Panjiayuan Nanli, Chaoyang District, Beijing (100021)
Langfang Campus: Guangyang District, Langfang, Hebei Province
Total Beds: ~2,700
Staff: 3,000+ employees, including 3 CAS Academicians, 4 CAE Academicians, 600+ senior professionals.
Annual Volume: 730,000+ outpatient visits; 110,000+ discharges; 30,000+ surgeries/year.
Core Strengths & National Key Specialties
NCC/CH-CAMS leads China in 5 National Key Disciplines and 6 National Key Clinical Specialties, with world-class expertise:
Thoracic Surgery (National No.1)
China’s leading center for lung, esophageal cancer; pioneer in minimally invasive & robotic surgery.
Annual complex thoracic surgeries: 10,000+ cases.
Pathology (National Reference Center)
Gold standard for cancer diagnosis in China; 150,000+ histopathology cases/year.
Radiation Oncology
One of Asia’s largest radiotherapy centers; advanced IMRT, IGRT, proton therapy (Langfang Campus).
Medical Oncology
Leader in chemotherapy, targeted therapy, immunotherapy; conducts ~80% of China’s national anti-cancer drug trials.
Head & Neck Surgery
Pioneer in thyroid, laryngeal, nasopharyngeal cancer treatment & functional preservation.
Other Flagship Departments
Hepatobiliary, Pancreatic-Gastric, Colorectal, Breast, Gynecologic Oncology; Neurosurgery; Urology; Interventional Radiation; Nuclear Medicine & PET-CT.
Research & Innovation
National Clinical Research Center for Cancer.
Hosts 1 State Key Laboratory (Molecular Oncology), 2 Beijing Key Labs.
Annual 1,000+ SCI papers (including Nature, Lancet, Cell); 200+ national awards (1 First-Class National Science & Technology Progress Award).
Develops national cancer diagnosis/treatment guidelines; operates National Cancer Registry.
Education & Training
First-class postgraduate training base of Peking Union Medical College.
4 Postdoctoral programs, 10 PhD, 12 Master’s programs.
Trains 800+ residents/fellows/PhDs yearly; national model for oncology education.
International Cooperation
Partners with WHO, IARC, NCI (US), MD Anderson, etc..
Hosts major global oncology conferences; trains international oncologists.
Core participant in global cancer control initiatives.
Contact Information
Address: 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, P.R. China
Tel: +86-10-6778-1331
Website: www.cicams.ac.cn (English: www.cicams.ac.cn/en)
Emergency: +86-10-6778-6778